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Abstract
Protein aggregation is associated with neurodegeneration. Polyglutamine expansion diseases such as spinobulbar muscular
atrophy and Huntington disease feature proteins that are destabilized by an expanded polyglutamine tract in their N-
termini. It has previously been reported that intracellular aggregation of these target proteins, the androgen receptor (AR)
and huntingtin (Htt), is modulated by actin-regulatory pathways. Sequences that flank the polyglutamine tract of AR and Htt
might influence protein aggregation and toxicity through protein-protein interactions, but this has not been studied in
detail. Here we have evaluated an N-terminal 127 amino acid fragment of AR and Htt exon 1. The first 50 amino acids of
ARN127 and the first 14 amino acids of Htt exon 1 mediate binding to filamentous actin in vitro. Deletion of these actin-
binding regions renders the polyglutamine-expanded forms of ARN127 and Htt exon 1 less aggregation-prone, and
increases the SDS-solubility of aggregates that do form. These regions thus appear to alter the aggregation frequency and
type of polyglutamine-induced aggregation. These findings highlight the importance of flanking sequences in determining
the propensity of unstable proteins to misfold.
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Introduction
Spinobulbar muscular atrophy (SBMA) and Huntington disease
(HD) are devastating neurodegenerative diseases. SBMA is caused
by an expanded CAG trinucleotide repeat that encodes a long
polyglutamine tract in the androgen receptor (AR) [1], while HD
is caused by an enlarged polyglutamine tract in the huntingtin
(Htt) protein [2]. Proteolytic cleavage of AR and Htt appears to
generate toxic, N-terminal fragments [3,4,5,6]. These are sufficient
to recapitulate neurodegenerative phenotypes in vivo [7,8]. N-
terminal fragments of expanded AR and Htt readily aggregate in
vitro and in cell-culture models, thus making them useful in
biochemical studies [9,10,11]. While the aggregation and toxicity
of polyglutamine proteins directly correlate with the length of the
polyglutamine tract [11], flanking sequences are also clearly
important [12,13,14], as are intracellular signaling pathways that
act via protein interactions or post-translational modifications
[10,15,16]. Emerging evidence from a variety of studies of
aggregation-prone proteins associated with neurodegenerative
diseases suggests that there is considerable diversity among
aggregates that can be formed in vitro [17,18,19], and, moreover,
that some protein aggregates are likely to be more toxic than
others [19,20]. Thus, protein interactions that alter aggregate
conformation could play an important role in determining toxicity.
Indirect evidence implicates actin and/or actin-binding factors
as an influence on polyglutamine-dependent aggregation of AR
and Htt [10,21,22,23,24,25,26]. Y-27632, a rho-kinase (ROCK)
inhibitor, reduces intracellular polyglutamine aggregation of Htt
exon 1 and the N-terminal fragment of AR, termed ARN127
[10,25]. Y-27632 also attenuates Htt toxicity in Drosophila and
improves motor function in mice [10,27]. Y-27632 blocks
phosphorylation of profilin, an actin-binding protein that directly
binds Htt, but not AR [28,29]. Profilin strongly inhibits
aggregation of ARN127 and Htt exon 1 in cells [29], and
decreases polyglutamine-mediated toxicity in Drosophila [22]. The
anti-aggregation effects of profilin depend on both its polyproline
binding activity (required to bind Htt), and its ability to bind G-
actin (required to suppress both Htt and AR aggregation) [29]. In
this study, we have identified regions of ARN127 and Htt exon
1that bind filamentous actin (F-actin) in vitro, and investigate the
effect of these regions on polyglutamine-dependent aggregation.
Results
ARN127 and Htt Exon 1 Bind F-Actin In Vitro
To test for a direct interaction between AR, Htt, and F-actin in
vitro, we used an F-actin co-sedimentation assay with recombinant
GST-ARN127 or GST-Htt exon 1 containing 25 glutamine
repeats (Fig. 1A). Coomassie staining confirmed protein purity
(Fig. S1A,E). Protein preparations were precleared by ultracentri-
fugation to remove any pre-existing aggregates. 0.5 mM GST-
ARN127(25) or 0.25 mM GST-Htt exon 1(25) was incubated with
F-actin (4 mM) that had been pre-polymerized in vitro for 1 hour at
25uC. As a control, proteins were incubated with an equal
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concentration of bovine serum albumin (BSA) instead of F-actin.
After ultracentrifugation (100,000 x g), supernatant and pellet
fractions were analyzed by western blot using antibody to GST.
Western blot analysis was used rather than Coomassie stain
because both proteins are very similar in size to G-actin (43 kDa).
F-actin localized to the pellet fraction in all cases, as visualized by
Coomassie stain (Fig. 1B). Both GST-ARN127(25) and GST-Htt
exon 1(25) co-sedimented with F-actin while remaining soluble in
its absence (Fig. 1B). GST alone did not co-sediment with F-actin
(Fig. 1B). ARN127 also bound F-actin following cleavage of the
GST-tag (Fig. S1B). We determined the binding affinity of GST-
ARN127(25) and GST-Htt exon 1(25) for F-actin by using a
constant amount of protein (16 nM for ARN127, 150 nM for Htt
exon 1) mixed with increasing amounts of F-actin (Fig. 1C, D).
GST-ARN127(25) bound to F-actin with an approximate
dissociation constant (Kd) of 1 mM (Fig. 1C), while for GST-Htt
exon1(25) the Kd was approximately 2 mM (Fig. 1D), comparable
to other actin-binding proteins [30].
Amino Acids 1-50 of ARN127 and 1-14 of Htt Exon 1
Mediate F-Actin Binding
We used deletion analysis to map the actin-binding regions of
ARN127 and Htt exon 1 (Fig. 2A,C). Protein purity was assessed
by Coomassie (Fig. S1A,C,E). Deletion of the polyglutamine
domain of ARN127 and peptides C-terminal to the polyglutamine
domain (AR1–57) had no appreciable effect on actin binding
(Fig. 2B), while deleting the N-terminal peptides of AR (AR50–127,
AR78–127) abolished binding (Fig. 2B). Constructs lacking the
polyglutamine tract (ARN127(DQ)), or containing an expanded
polyglutamine tract (ARN127(52)) bound actin equivalently
(Fig. 2B). A very pure extract of AR1–57 cleaved from the GST-
tag also bound F-actin efficiently (Fig. S1D). Deletion of peptides
C-terminal to the polyglutamine tract of Htt exon 1 (Htt1–45) had
no effect on binding while deletion of the first 14 amino acids
(Htt15–92) abolished binding (Fig. 2C,D). Thus, the first 50 amino
acids (N50) of AR and the first 14 amino acids (N14) of Htt
Figure 1. ARN127 and Htt exon 1 directly bind to F-actin in
vitro. A, Schematic of GST-tagged N-terminal fragments of AR and Htt,
GST-ARN127 and GST-Htt exon 1, in comparison to full-length AR (FL-
AR) and full-length Htt (FL-Htt). B, GST-ARN127(25) and GST-Htt exon
1(25) co-sediment with F-actin in vitro but remain soluble in the
absence of F-actin. 0.5 mM of precleared GST-ARN127(25) or .25 mM of
precleared GST-Htt exon 1(25) was mixed with 4 mM of pre-polymerized
F-actin. Mixtures were ultracentrifuged at 100,000 x g and supernatant
and pellet fractions were analyzed via western blot (ARN127 and Htt
exon 1) and Coomassie (actin). GST alone does not co-sediment with F-
actin. C, Binding affinity of GST-ARN127(25) to F-actin. The F-actin co-
sedimentation assay was performed with 0, .5 mM, 1 mM, 2 mM, 4 mM,
and 8 mM F-actin and .016 mM GST-ARN127(25). Gels were quantified to
determine the percent bound to F-actin. Percent maximal binding is
reported. D, Binding affinity of GST-Htt exon 1(25) to F-actin. The F-actin
co-sedimentation assay was performed with 0, .5 mM, 1 mM, 2 mM,
4 mM, 8 mM, and 16 mM F-actin and .15 mM GST-Htt exon 1(25). Gels
were quantified to determine the percent bound to F-actin using
Image J.
doi:10.1371/journal.pone.0009053.g001
Figure 2. N50 of ARN127 and N14 of Htt exon 1 mediate F-actin
binding in vitro. A, Schematic of GST-ARN127 and various truncation
mutants. B, The N-terminus of ARN127 binds to F-actin in vitro. GST-
tagged truncations of ARN127(25) (AR1–57, AR50–127, AR78–127 (20 nM)),
were tested for binding to F-actin (4 mM). ARN127(25) and AR1–57 co-
sediment with F-actin while AR50–127 and AR78–127 do not. GST-tagged
ARN127(DQ) or ARN127(52) (0.5 mM) both co-sediment with F-actin. C,
Schematic of GST-Htt exon 1 and GST-tagged truncation mutants. D,
The N-terminus of Htt exon 1 binds to F-actin in vitro. GST-tagged
Htt1–45 (0.1 mM) binds to F-actin (4 mM) while Htt15–92 (0.1 mM) does not.
doi:10.1371/journal.pone.0009053.g002
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mediate interactions with F-actin in vitro. There is no apparent
homology between these regions.
Sensitivity to Actin-Regulatory Pathways Requires the
First 50 Amino Acids of ARN127
We have previously found that Y-27632, as well as a
downstream ROCK target, profilin, inhibit ARN127 and Htt
exon 1 aggregation [10,25,29]. Since both Y-27632 and profilin
regulate actin assembly [31,32], we tested whether deletion of the
actin-binding region of ARN127 would alter its response to their
inhibitory activities. We employed fluorescence resonance energy
transfer (FRET) to quantify these effects [10]. We were only able
to test AR using this assay, since deletion of the N14 region of Htt
prevented significant FRET, possibly due to altered orientation of
the CFP and YFP moieties. Expanded ARN127 and ARQC with
65 glutamines were tagged with fluorescence donor or acceptor
tags, CFP or YFP, and co-transfected into HEK293 cells as
previously described [10]. Y-27632 decreased ARN127(65)-CFP/
YFP aggregation dose-dependently (Fig. 3A). Intriguingly, it
increased the aggregation of ARQC(65)-CFP/YFP (Fig. 3A).
Similarly, profilin 1 dose-dependently reduced ARN127(65)-CFP/
YFP aggregation, but was much less effective on ARQC(65)-CFP/
YFP aggregation (Fig. 3B). Thus, the N50 region of AR mediates
effects of these actin regulators on polyglutamine-mediated
aggregation.
N50 of ARN127 Affects Inclusion Type, Number, and
Distribution
To better characterize the behavior of expanded AR and Htt
peptides within the cell, and to determine the influence of the
actin-binding regions, we transfected expanded forms of each
construct into C17.2 neural precursor cells, which were used for
their ease of imaging. Identical results were obtained with
HEK293 cells (data not shown). We observed clear differences
between inclusions formed by ARN127(65)-YFP vs. ARQ-
C(65)YFP. ARN127(65)-YFP formed many different types of
inclusions (single, multiple, nuclear, cytoplasmic), whereas ARQ-
C(65)YFP tended to form one perinuclear inclusion (Fig. 4A–F).
After 48 h post-transfection, ARN127(65)-YFP expression resulted
in multiple inclusions per cell in ,57% of cells vs. ,23% for
ARQC(65)-YFP (Fig. 4G). ARN127(65)-YFP produced nuclear
inclusions in ,19% of cells vs. ,5% of cells for ARQC(65)-YFP
(Fig. 4H). These data are consistent with the idea that protein
interactions mediated by the N50 domain of AR could alter the
type of protein aggregates, as well as their subcellular localization.
In contrast, we did not observe obvious inclusion differences
between Htt exon 1 and HttQC. Htt exon 1(72)-YFP and
HttQC(72)-YFP formed inclusions with similar visual character-
istics (data not shown) as did Htt exon 1(97)-H4 and HttQC(97)-
H4 (Fig. 4I-N), which contain a HIS-HA-HA-HIS epitope tag [33]
(Fig. 5B).
N50 of ARN127 and N14 of Htt Exon 1 Promote Inclusion
Formation
To quantify the effect of N50 of ARN127 and N14 of Htt exon
1 on intracellular aggregation, we transiently transfected HEK293
cells with expanded AR constructs (ARN127(65)-YFP or
ARQC(65)-YFP) or Htt constructs (Htt exon 1(72)-YFP or
HttQC(72)-YFP; Htt exon 1(97)-H4 or HttQC(97)-H4, which
contain a HIS-HA-HA-HIS epitope tag) and cultured the cells for
24 h (Fig. 5A–E). In each case, the QC proteins produced
significantly fewer visible inclusions (Fig. 5C–E). Biochemical
analysis of total cell lysates after 24 h in 2% SDS revealed that the
soluble fractions of both ARQC(65)-YFP and HttQC(72)-YFP
were enriched, while the SDS-insoluble aggregates, were depleted
(Fig. 5F–H). Thus, N50 of ARN127 and N14 of Htt exon 1
each promote the formation of inclusions and SDS-insoluble
aggregates.
N50 of ARN127 and N14 of Htt Exon 1 Promote SDS-
Insoluble Aggregates
The distinct effects of actin-binding regions on AR and Htt
inclusion formation suggested that they might also change
aggregate characteristics. Thus, we transfected HEK293 cells with
the various constructs as above. 24 h post-transfection the cells
were disrupted via syringe lysis and fractionated by centrifugation
(15,000 x g) to compare soluble vs. insoluble species. Supernatant
and pellet fractions were resuspended in 2% SDS and resolved by
SDS-PAGE and western blot. All protein in the supernatant
fraction was completely solubilized by SDS (Fig. 6A). In contrast,
both ARN127(65)-YFP and ARQC(65)-YFP peptides that parti-
tioned into the insoluble pellet contained mixtures of SDS-soluble
Figure 3. N50 of ARN127 mediates aggregation inhibition by
actin- regulatory pathways. A, Y-27632 inhibits aggregation of
ARN127(65)-CFP/YFP and increases ARQC(65)-CFP/YFP aggregation.
Cells expressing either ARN127 or ARQC fused to CFP/YFP were treated
with 10, 30, or 100 mM Y-27632 for 24 hours. Relative FRET/donor
measurements represent the change in aggregation from compounds
compared to untreated cells. Y-27632 suppressed ARN127(65)-CFP/YFP
aggregation, whereas it increased ARQC(65)-CFP/YFP aggregation. B,
Profilin 1 decreases aggregation of ARN127(65)-CFP/YFP dose-depen-
dently. Profilin 1 was cotransfected with polyglutamine proteins at
increasing amounts, .075, .15, or .225 mg. This response was diminished
for ARQC(65)-CFP/YFP. (* = p,.01, ** = p,.0001, Student’s t-test).
doi:10.1371/journal.pone.0009053.g003
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Figure 4. N50 of ARN127 influences inclusion type, number, and distribution. A–C, Confocal images of ARN127(65)-YFP inclusions in C17.2
cells at 48 h (60X). D–F, Confocal images of ARQC(65)-YFP inclusions in C17.2 cells at 48 h (60X). YFP-tagged proteins are in green, F-actin is stained
with rhodamine-phalloidin (red) and DNA is stained with DAPI (blue). G, ARN127(65)-YFP more often forms multiple inclusions per cell than ARQC(65)-
YFP (* = p,.002, Student’s t-test). H, ARN127(Q65)-YFP more often forms nuclear inclusions per cell than ARQC(65)-YFP (* = p,.002, Student’s t-test).
Averages are from three separate transfections, counting at least 100 cells each. I-K, Confocal images of Htt exon 1(97)-H4 in C17.2 cells at 48 h (60X).
L-N, Confocal images of HttQC(97)-H4 in C17.2 cells at 48 h (60X). Immunofluorescence of HA-tagged Htt is in green, F-actin is stained with
rhodamine-phalloidin (red) and DNA is stained with DAPI (blue). We did not observe significant differences in patterns of inclusion formation
between the two Htt constructs.
doi:10.1371/journal.pone.0009053.g004
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and insoluble proteins (Fig. 6A,B). The aggregates of ARQC(65)-
YFP were much more readily dissociated in 2% SDS compared to
ARN127(65)-YFP (Fig. 6A,B). Parallel experiments in C17.2 cells
revealed similar results (Fig. 6A). We observed similar phenomena
for Htt exon 1(97)-H4 vs. HttQC(97)-H4 (Fig. 6C). The pellet
fraction containing HttQC(97)-H4 was significantly more SDS-
Figure 5. N50 of ARN127 and N14 of Htt exon 1 increase inclusion formation and detergent insolubility of aggregates. HEK293 cells
were transfected with the indicated constructs and evaluated after 24 h. A, Schematic of AR fusion proteins, not to scale. B, Schematic of Htt fusion
proteins, not to scale. The H4 sequence represents HIS-HA-HA-HIS epitopes. C, ARN127(65)-YFP forms more inclusions than ARQC(65)-YFP
(* = p,.0025, Student’s t-test). D, Htt exon 1(72)-YFP forms more inclusions than HttQC(72)-YFP (* = p,.0025, Student’s t-test). E, Htt exon 1(97)-H4
forms more inclusions than HttQC(97)-H4 (* = p,.005, Student’s t-test). F, ARN127(65)-YFP and Htt exon 1(72)-YFP form more SDS-insoluble
aggregates than ARQC(65)-YFP and HttQC(72)-YFP. HEK293 cells were transiently transfected with the indicated constructs. After 24 h, cells were
lysed in 2% SDS sample buffer, and subjected to SDS-PAGE and western blot with YFP antibody. Stack indicates the SDS-insoluble higher molecular
weight aggregates trapped in the stacking gel; Sol indicates the SDS-soluble monomers. Tubulin indicates loading control. Deletion of amino
terminal peptides reduced the overall proportion of SDS-insoluble material detected in the stacking gel. G, Quantification of relative insoluble to
soluble fractions of ARN127 vs. ARQC (n= 3, * = p,.05, Student’s t-test). H, Quantification of relative insoluble to soluble fractions of Htt exon 1 vs.
HttQC (n = 3, * = p,.05, Student’s t-test). Quantification by Image J.
doi:10.1371/journal.pone.0009053.g005
Cellular Protein Aggregation
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soluble (Fig. 6C,D). Thus flanking sequences of AR and Htt
influence both the propensity for protein misfolding and the
biochemical characteristics of the aggregates that result.
Discussion
In this study, we have focused on aggregation-prone fragments
of AR (ARN127) and Htt (Htt exon 1), identifying amino acids 1–
50 (N50) of ARN127 and 1–14 (N14) of Htt exon1 as regions that
influence polyglutamine-dependent aggregation. These regions
were originally identified because they mediate binding to F-actin
in vitro. However, we did not observe co-localization of ARN127 or
Htt exon 1 with the F-actin cytoskeleton (data not shown). This
could reflect lack of significant binding, or that intracellular
binding to F-actin is transient. Deletion of the N50 region of
ARN127 or the N14 region of Htt decreased the total number of
inclusions formed, and the aggregates that did form were more
SDS-soluble. Further, the N50 region of AR regulates the
characteristics of inclusions formed and mediates its responsiveness
to the anti-aggregation effects of Y-27632 and profilin. Thus, the
flanking sequence of the polyglutamine region does not simply
alter the propensity to form a polyglutamine aggregate, but can
directly affect its aggregation rate and responses, the subcellular
localization of the inclusions, and the biochemical characteristics
of the aggregates.
The importance of flanking sequences on Htt exon 1 has
previously been demonstrated: flanking sequences have been
shown to directly regulate aggregation, toxicity, and the
morphology of inclusions [13,34,35]. Given the importance of
primary amino acid sequence on polyglutamine aggregation in vitro
[12,14], we cannot exclude that the intracellular aggregation
differences observed are solely due to altered intrinsic aggregation
kinetics. However, this cannot explain all observable differences
noted, such as altered distribution of polyglutamine inclusions. We
have found that peptides containing either the first 50 amino acids
of AR or the first 14 amino acids of Htt partition to Triton-
insoluble cell fractions independent of their inherent solubility
(Figs. S2, S3), suggesting that these regions could mediate protein
interactions with macromolecular structures in the cytoplasm.
Indeed, the first 17 amino acids of Htt have previously been
implicated as a pro-aggregation-domain, a cytoplasm-targeting
domain, and have been shown to bind mitochondria, the
endoplasmic reticulum, and the Golgi apparatus [35,36]. This
region is highly conserved across diverse species. Taken together,
these studies imply that this region is likely to mediate protein
interactions that play an important role in determining aggrega-
tion properties of the Htt peptide.
Although we did not detect binding of AR or Htt to F-actin in
cells, the in vitro binding of the Htt N-terminus to F-actin is
intriguing in light of Htt’s capacity also to bind the actin
remodeling factor profilin. Profilin/Htt interaction is most likely
mediated by Htt’s polyproline domain, immediately distal to the
polyglutamine region in the Htt peptide [28,29]. Analysis of the
first 17 amino acids of Htt reveal a striking similarity to another
actin-binding peptide, Lifeact [37]. These observations may
indicate a normal, perhaps transient, function for Htt in the
regulation of the actin cytoskeleton, although this remains to be
tested.
In this study, we find that sequences independent of the
polyglutamine tract have profound effects on subcellular localiza-
tion, detergent solubility, and inclusion formation of polygluta-
mine peptides. Given the apparent importance of these regions for
protein interaction, this implies that modifiers of protein
aggregation are likely to be found within the set of AR and Htt
interacting proteins. Indeed, the recent finding that Htt-interacting
proteins are enriched for genetic modifiers of toxicity is consistent
with this idea [38]. Further study of AR and Htt binding proteins
thus may reveal mechanisms that specify particular aggregation
pathways and pathogenic features of each disease.
Materials and Methods
Constructs
Bacterial expression vectors for ARN127 Htt exon 1 and
various derivatives were constructed via PCR amplification and
subcloned in the pGEX4T1 backbone (Amersham Biosciences).
Similarly, for mammalian expression vectors, ARQC and HttQC
plasmids were constructed via PCR amplification and subcloned
into pECFP-N1, pEYFP-N1 (Clontech), or pcDNA.3 backbones.
GST-Htt exon 1 constructs were originally obtained from Paul
Figure 6. N50 of ARN127 and N14 of Htt exon 1 increase SDS-
insoluble aggregate formation. A, ARN127(65)-YFP forms more
SDS-insoluble aggregates than ARQC(65)-YFP. HEK293 and C17.2 cells
were transiently transfected with either ARN127(65)-YFP or ARQC(65)-
YFP. After 24 h, cells were syringe lysed and fractionated by
centrifugation at 15,000 x g. Supernatant and pellet fractions were
then resuspended in 2% SDS sample buffer and subjected to SDS-PAGE
and western blot with YFP antibody. The soluble portions are shown in
the upper panels, while the insoluble portions are shown in the lower
panels. Stack indicates the SDS-insoluble higher molecular weight
aggregates in the stacking gel; Sol indicates the SDS-soluble monomers.
B, Quantification of SDS-insoluble aggregates for ARN127(65)-YFP and
ARQC(65)-YFP from HEK293 cells after 24 h. The insoluble fraction of
ARN127(65)-YFP has significantly more SDS-insoluble material than
ARQC(65)-YFP (n = 3, * = p,.001, Student’s t-test). C, Htt exon1(97)-H4
forms more insoluble aggregates than HttQC(97)-H4 in HEK293 cells
after 24 h. Cells were treated as above and subjected to SDS-PAGE and
western blot with HA antibody. D, Quantification of SDS-insoluble
aggregates for Htt exon1(97)-H4 and HttQC(97)-H4 from HEK293 cells
after 24 h. The insoluble fraction of Htt exon 1(97)-H4 has significantly
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Muchowski and mammalian pcDNA3-Htt-H4 constructs were
originally obtained from Joan Steffan.
Cell Culture and Transfection
HEK293 cells were plated at 250,000 cells per well in a 24-well
dish and transfected with .3 mg total DNA with Lipofectamine and
Plus reagent (Invitrogen) according to the manufacturer’s
instructions. C-17.2 cells were plated at 100,000 cells per 24-well
and transfected with .6 mg DNA with Lipofectamine 2000
(Invitrogen) according to the manufacturers instructions. Cells
were harvested at indicated times.
FRET
All FRET measurements were carried out 48 hours after
transfection of HEK293 cells, read in 96-well cell-culture plates
by a fluorescence plate reader (Tecan). HEK293 cells were
transfected with .075 mg total ARN127CFP/YFP DNA in a 1:3
donor:acceptor ratio. Profilin DNA was co-transfected with AR
constructs at concentrations of .075 mg, .15 mg, or .225 mg.
pcDNA3 backbone vector was also co-transfected for a constant
final concentration of .3 mg. Y-27632 was added at the indicated
concentration for 24 h prior to FRET measurements[29].
Confocal Microscopy
All images were acquired on a C1sl confocal microscope (Nikon
Instruments Inc.).
Immunofluorescence
C17.2 cells were mounted on polyornithine-coated glass
coverslips 48 hours after transfection at a density of 20,000 cells
per coverslip for 60X imaging. Cells were fixed in 4%
paraformaldehye, treated with .5% Triton, and blocked in 5%
BSA for 1 hour. Coverslips were treated with HA antibody (1:500,
Covance) overnight at 4uC, rinsed 4X and washed 3X with %1
TBS-Tween, and treated with donkey-anti-mouse Alexa-Fluor 488
(1:400, Molecular probes) for 1 h at 37uC. Coverslips were rinsed
4X and washed 2X with %1 TBS-Tween. F-actin was visualized
with rhodamine-conjugated phalloidin (1:300, Molecular Probes)
and the nucleus was stained with DAPI (Sigma). Coverslips were
mounted with anti-fade mounting media (Invitrogen) and analyzed
24 h later.
Inclusion Counting
At least 100 HEK293 cells per transfection (3) were examined
for total number of inclusions formed after 24 h. Approximately
100 C17.2 cells per transfection (3) were counted for inclusions.
Cells were identified as having nuclear, cytoplasmic, or multiple
inclusions, or a combination.
Protein Purification
GST-ARN127 plasmids were grown in E. Coli Rosetta 2 (DE3)
competent cells (Novagen). Protein expression was induced with
1 mM (isopropyl b-d-thiogalactoside) IPTG for 3 h at 37uC.
GST-Htt plasmids were grown in E. Coli SURE competent cells
(Stratagene). Protein expression was induced with 1 mM IPTG
for 3H at 30uC. Bacterial pellets were resuspended in resuspen-
sion buffer (PBS, .05% Tween, 1 mM PMSF, protease inhibitor
tablet (Roche)) and lysed by sonication and 1% Triton. GST-
tagged proteins were precipitated with glutathione sepharose
(Amersham Biosciences) and eluted with equal volumes of elution
buffer (50 mM Tris-HCl pH. 8 m 10 mM reduced glutathione).
For cleavage of the GST-tag, 37.5 units of thrombin protease
(Amersham Biosciences) was used for .5 ml of GST-bound
glutathione sepharose 4B (Amersham Sepharose) at 4uC over-
night. Thrombin was removed from cleaved AR with benzami-
dine sepharose 6B (Amersham Biosciences). Protein concentra-
tion was quantified via Bradford assay and Coomassie staining via
Image J.
F-Actin Co-Sedimentation
Non-muscle human actin (Cytoskeleton) was polymerized
according to the manufacturer’s instructions. 10 mg/ml of G-
actin was polymerized with polymerization buffer (10X: 500 mM
KCl, 20 mM MgCl2, 10 mM ATP) in general actin buffer (5 mM
Tris-HCl pH8.2 mM CaCl2, .5 mM DTT, .2 mM ATP) for 1 h
at RT. Equal molar ratios of unlabeled phalloidin (Molecular
Probes) were added to stabilize filaments. Recombinant, purified
GST-tagged proteins were precleared via ultracentrifugation
(100,000 x g for 30 min at 4uC). Proteins were added to a pre-
polymerized F-actin (4 uM) or a BSA control for 1 h on ice.
Mixtures were ultracentrifuged for 30 min at 100,000 x g at 4uC.
Supernatants and pellets were subjected to SDS-PAGE. F-actin
pellets were visualized via Coomassie stain. GST-proteins were
probed via western blot using GST antibody (Santa Cruz
Bioscience).
Detergent Fractionation
For unexpanded AR and Htt constructs, HEK293 cells were
harvested 24 h post-transfection. Cell pellets were lysed in 130 ml
cold lysis buffer (PBS, 1 % Triton, 5 mM EDTA, protease
inhibitor cocktail (Roche)) and subjected to high-speed ultracen-
trifugation (100,000 x g). For expanded AR and Htt constructs,
HEK293 cells were harvested 24 h later post-transfection. Cell
pellets were lysed by syringe passage in cold resuspension buffer
(PBS, 5 mM EDTA, protease inhibitor cocktail (Roche)) and
subjected to table-top centrifugation (15,000 x g). Supernatant and
pellets fractions were denatured in 2% SDS buffer, 25 mM DTT,
and boiled for 10 min. For crude cell-lysates, cell pellets were
directly lysed in 200 ml of 2% SDS, 25 mM DTT and boiled for
10 minutes. All lysates were subjected to SDS-PAGE and probed
via western blot using GFP antibody (Santa Cruz Biotechnology)
or HA antibody (Covance). Supernatants, pellets and higher
molecular weight bands were quantified using Image J.
Antibodies
Anti-rabbit N-20 antibody (1:1000, Santa Cruz) was used for
the detection of cleaved AR products. Anti-rabbit GFP-antibody
(Santa Cruz) or anti-mouse HA-antibody (Covance) was used for
the detection of YFP-tagged or HA-tagged proteins at 1:2000
dilution for soluble proteins or 1:1000 dilution for insoluble
higher-molecular weights. Anti-mouse MW7 was used to detect
the C-terminus of Htt at 1:2000 dilution for soluble proteins or
1:1000 dilution for insoluble higher-molecular weights.
Anti-mouse GST-antibody (1:2000, Santa Cruz) was used for
the detection of GST-tagged proteins.
In Vitro Solubility
GST-ARN127(25), GST-ARNQ(32), GST-ARQC(36), GST-
Htt exon 1(25), and GST-HttQC(25) were recombinantly purified
and quantified as described above. 1.25 mg/ml of GST-AR or
.75 mg/ml of GST-Htt purified proteins were ultracentrifuged
(100,000 x g) and incubated at 37uC for 1 h to promote
misfolding. For cleavage of the GST tag, 1.0 mg/ml of precleared
GST-AR peptide were incubated with 1 NIH unit of thrombin
(Invitrogen) overnight at 4uC. Proteins were ultracentrifuged and
supernatant and pellet fractions were resuspended in SDS sample
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buffer and subjected to SDS-PAGE. Proteins were analyzed via
Coomassie stain.
Supporting Information
Figure S1 Purity of Recombinantly Purified Proteins. A,
Coomassie stain of GST-ARN127(25), GST-ARN127(DQ), and
GST-ARN127(52). Lower molecular weight (LMW) contaminants
are indicated B, Cleaved ARN127(25) co-sediments with F-actin
but is soluble in the absence of F-actin. GST-tagged ARN127(25)
was treated with thrombin to cleave off the GST tag. 1 mM of
thrombin-cleaved ARN127(25) was mixed with 5 mM F-actin as in
Figure 1. Western blot was used to detect the N-terminus of AR
(N-20 antibody) or Coomassie for actin. C, Coomassie stain of
GST and GST-AR fragments, AR1-57, AR50-127, and AR78-
127, D, Cleaved AR1-57 cosediments with F-actin but is soluble in
the absence of F-actin. GST-tagged AR1-57 was treated with
thrombin to cleave off the GST tag. 1 mM of thrombin-cleaved
AR1-57 was mixed with 5 mM F-actin. Western blot was used to
detect the N-terminus of AR (N-20 antibody) or Coomassie stain
for actin. E, Coomassie stain of GST-Htt exon 1(25), GST- Htt1-
45, and GST- Htt15-92.
Found at: doi:10.1371/journal.pone.0009053.s001 (5.47 MB TIF)
Figure S2 N50 of ARN127 and N14 of Htt exon 1 mediate
macromolecular interactions. A, Schematic of AR and Htt
peptides fused to YFP. B, The N-terminus of AR mediates
macromolecular interactions. HEK293 cells were transfected with
YFP fusion proteins, lysed in 1% Triton, and subjected to
ultracentrifugation (100,000 x g). Supernatant and pellet fractions
were analyzed via western blot with YFP antibody. ARN127(25)-
YFP (top band) and ARNQ(25)-YFP are present in the Triton-
insoluble pellets of HEK293 cells, while ARQC(25)-YFP is not.
Tubulin indicates loading control. C, Deletion of the N14 region
of Htt exon 1(25) does not affect Triton solubility. Supernatant
and pellet fractions were analyzed via western blot with MW7
antibody (detects the C-terminus of Htt). Tubulin indicates loading
control. D, The first 17aa of Htt alone fused to YFP cause it to
become insoluble in cell lysates. Blots are probed with YFP.
Tubulin indicates loading control.
Found at: doi:10.1371/journal.pone.0009053.s002 (9.60 MB TIF)
Figure S3 Inherent Solubility of GST peptides. A, There are no
differences in the inherent solubility of AR peptides. GST-tagged
ARN127(25), ARNQ(32), and ARQC(36) are present in equal
amounts in the pellet fractions after ultracentrifugation. B,
Cleavage of AR peptides from GST does not unmask drastic
differences in inherent solubility. GST was cleaved from
ARN127(25), ARNQ(32), and ARQC(36) with thrombin protease
at 4uC overnight. Peptides were ultracentrifuged (100,000 x g) and
supernatant and pellet fractions were analyzed via SDS-PAGE
and Coomassie stain.
Found at: doi:10.1371/journal.pone.0009053.s003 (8.09 MB TIF)
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